Key result
Membrane-incorporated PIP2 directly inhibits KirBac1.1 channel activity without modulating KcsA.
Why the study?
Direct evidence for a specific interaction between phosphoinositides and ion channels was critically lacking.
This study provides direct evidence that PIP2 modulates KirBac1.1 channel gating through a direct interaction in the membrane, excluding indirect modulation via cytoskeletal elements.
Supports direct phosphoinositide-Kir interaction in vitro; leaves open physiologic roles in native cardiac myocytes.
Multiple ion channels have now been shown to be regulated by phosphatidylinositol 4,5-bisphosphate (PIP2) at the cytoplasmic face of the membrane. However, direct evidence for a specific interaction between phosphoinositides and ion channels is critically lacking. We reconstituted pure KirBac1.1 and KcsA protein into liposomes of defined composition (3:1 phosphatidylethanolamine:phosphatidylglycerol) and examined channel activity using a 86Rb+ uptake assay. We demonstrate direct modulation by PIP2 of KirBac1.1 but not KcsA activity. In marked contrast to activation of eukaryotic Kir channels by PIP2, KirBac1.1 is inhibited by PIP2 incorporated in the membrane (K(1/2) = 0.3 mol %). The dependence of inhibition on the number of phosphate groups and requirement for a lipid tail matches that for activation of eukaryotic Kir channels, suggesting a fundamentally similar interaction mechanism. The data exclude the possibility of indirect modulation via cytoskeletal or other intermediary elements and establish a direct interaction of the channel with PIP2 in the membrane.
No takes yet. Share an insight, caveat, or question.
Enkvetchakul et al. (2005) studied this question. Phosphatidylinositol 4,5-bisphosphate (PIP2) was evaluated on Channel activity using a 86Rb+ uptake assay. Membrane-incorporated PIP2 directly inhibited KirBac1.1 channel activity (K(1/2) = 0.3 mol %) but did not modulate KcsA activity, establishing a direct interaction mechanism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: